CARDIOVASCULAR SYSTEMS INC (CSII)       13.3  +0.09 (+0.68%)

13.3  +0.09 (+0.68%)

US1416191062 - Common Stock - After market: 13.3 0 (0%)


Fundamental Rating

3

Overall CSII gets a fundamental rating of 3 out of 10. We evaluated CSII against 221 industry peers in the Health Care Equipment & Supplies industry. The financial health of CSII is medium. Also its profitability is quite bad. While showing a medium growth rate, CSII is valued expensive at the moment.




Profitability

Profitability Rating

1

CSII has a Return On Assets of -11.45%. This is comparable to the industry average of -17.37%.
CSII's Profit Margin of -15.63% is in line with the rest of the industry. The industry average Profit Margin is -27.20%.

The profitability ratios for CSII are negative, so there is not much use analyzing them.
The Piotroski-F score of CSII is 2.00. This is a very weak score and indicates problems in health and profitability for CSII.
VS Industry

ROA (-11.45%) VS Industry: 57% outperformed.

-771.54
181.55

Profit Margin (-15.63%) VS Industry: 57% outperformed.

-110,533.33
2,317.41

Valuation

Valuation Rating

1

With a price book ratio of 2.18, CSII is valued correctly.
Compared to an average industry price book ratio of 2.43, CSII is valued in line with its industry peers.

CSII reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CSII is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
VS Industry

Price/Book (2.18) VS Industry: 52% outperformed.

77.76
0.22

Growth

Growth Rating

5

Based on estimates for the next 5 years, CSII will show a quite strong growth in Revenue. The Revenue will grow by 10.81% on average per year.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
Based on estimates for the next 5 years, CSII will show a small growth in Earnings Per Share. The EPS will grow by 6.62% on average per year.

CSII shows a decrease in Revenue. In the last year, the revenue decreased by -8.78%.
Measured over the past 5 years, CSII shows a small growth in Revenue. The Revenue has been growing by 2.89% on average per year.
CSII shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -265.38%.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -265.38% 28.77% 20.81% 16.59% 6.62%
Revenue2.89% -1.61% -8.78% 9.18% 9.79% 10.9% 10.81%

Health

Health Rating

6

CSII has a Current Ratio of 6.05. This indicates that CSII is financially healthy and has no problem in meeting its short term obligations.
When comparing the Current Ratio to an average industry Current Ratio of 3.81, CSII is better placed than the average industry peer to meet its short term obligations.
A Quick Ratio of 5.19 indicates that CSII has no problem at all paying its short term obligations.
CSII is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 3.01.

An Altman-Z score of 3.62 indicates that CSII is not in any danger for bankruptcy at the moment.
The Altman-Z score of CSII is much better than the industry average of 1.74.
The Debt to Equity ratio of CSII is in line with the industry averages.
CSII has a very weak Piotroski-F score of 2.00. This is an indication of health and profitability issues for CSII.
VS Industry

Debt/Equity (0.08) VS Industry: 52% outperformed.

24.10
0.00

Quick Ratio (5.19) VS Industry: 72% outperformed.

0.06
42.42

Current Ratio (6.05) VS Industry: 72% outperformed.

0.13
43.50

Altman-Z (3.62) VS Industry: 65% outperformed.

-105.17
49.93

Dividend

Dividend Rating

0

No dividends for CSII!.

CSII Daily chart

CARDIOVASCULAR SYSTEMS INC13.3

NASDAQ:CSII (9/27/2022, 7:00:01 PM)+0.09 (+0.68%)

After market: 13.3 0 (0%)

Chartmill FA Rating
GICS Sector Health Care
GICS IndustryGroup Health Care Equipment & Services
GICS Industry Health Care Equipment & Supplies
Earnings (Last) 08-02 2022-08-02/amc Earnings (Next) 11-07 2022-11-07
Ins Owners 4.32% Inst Owners 93.09%
Market Cap 544.83M Analysts 53.33
Valuation
PE N/A Fwd PE N/A
PEG (NY) N/A PEG (5Y) N/A
P/S 2.31 P/B 2.18
EV/EBITDA -12.68
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A
Growth
EPS 1Y -265.38% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q -78.57%
EPS Next Y 28.77% EPS Next 2Y 20.81%
EPS Next 3Y 16.59% EPS Next 5Y 6.62%
Revenue growth 1Y -8.78% Revenue growth 3Y -1.61%
Revenue growth 5Y 2.89% Revenue growth Q2Q -11.96%
Revenue Next Year 9.18% Revenue Next 2Y 9.79%
Revenue Next 3Y 10.9% Revenue Next 5Y 10.81%
Health
Current Ratio 6.05 Quick Ratio 5.19
Altman-Z 3.62 F-Score 2
Debt/Equity 0.08
Profitability
ROA -11.45% ROE N/A
ROIC N/A ROICg N/A
PM -15.63 OM -15.16
Asset Turnover 0.73

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA